Growth hormone and fertility in oMt1a-oGH transgenic mice.
Female mice carrying a regulatable growth hormone transgene (oMt1a-oGH) are subfertile when the transgene is actively expressed. This study was designed to characterize subfertility caused by increased concentrations of growth hormone. In particular, this study aimed to: (i) determine the effects of transgene activation and inactivation on mating, conception, maintenance of pregnancy, ovulation rate, litter characteristics and embryonic survival at day 17 of pregnancy, (ii) characterize oestrous cyclicity in transgenic versus wild-type female mice, and (iii) correlate corticosterone concentrations with transgene expression and reproductive performance. Transgenic and wild-type female mice were allocated randomly to one of four treatment groups at weaning: (i) transgenic female mice that always express the transgene, (ii) transgenic female mice that never express the transgene, (iii) transgenic female mice that express the transgene for up to 8 weeks of age and (iv) non-transgenic wild-type female mice receiving the transgene stimulus until 8 weeks of age. Activation followed by inactivation of the transgene resulted in an increased incidence of remating, resulting in an extended interval to establish pregnancy in comparison with all other treatment groups. Transgenic mice that always expressed the transgene and those that expressed the transgene for up to 8 weeks of age had lower pregnancy rates and higher ovulation rates compared with mice from other treatment groups. Both embryonic survival and the duration of the oestrous cycle did not differ among treatment groups. Active expression of the transgene resulted in an increase in the plasma concentration of corticosterone, which was associated with reduced fertility. These data indicate that the presence of a high growth hormone concentration impedes the establishment and maintenance of pregnancy. Increased plasma corticosterone concentrations may interfere with implantation as well as potentiate leptin resistance, which has been reported previously in studies with these mice.
Thomas
A D
AD
Department of Animal Science, University of California, Davis, CA 95616-8521, USA.
Murray
J D
JD
Famula
T R
TR
Oberbauer
A M
AM
D000704:Analysis of Variance; D000818:Animals; D003345:Corticosterone / Q000097:blood; D010064:Embryo Implantation; D030762:Estrous Cycle; D005260:Female; D005313:Fetal Death; D015870:Gene Expression / Q000187:drug effects; D013006:Growth Hormone / Q000235:genetics / Q000502:physiology*; D007247:Infertility, Female / Q000097:blood / Q000209:etiology*; D008098:Litter Size; D051379:Mice; D008822:Mice, Transgenic; D010060:Ovulation; D011247:Pregnancy; D011897:Random Allocation; D019287:Zinc Sulfate / Q000494:pharmacology
D019287:Zinc Sulfate; D013006:Growth Hormone; D003345:Corticosterone